Probiotics for prevention of atopic diseases in infants: Systematic review and meta-analysis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 70, Issue 11, 2015, Pages 1356-1371

  Zuccotti, G ^a   Meneghin, F ^b   Aceti, A ^c   Barone, G ^d   Callegari, M L ^e   Di Mauro, A ^f   Fantini, M P ^g   Gori, D ^g   Indrio, F ^f   Maggio, L ^d   Morelli, L ^e   Corvaglia, L ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e UCSC   (Italy)

^f UNIVERSITY OF BARI   (Italy)

^g UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

atopic diseases; infant; meta analysis; probiotic

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT;

AIRWAY OBSTRUCTION; ALLERGIC URTICARIA; ARTIFICIAL MILK; ASTHMA; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BIFIDOBACTERIUM LONGUM; CHRONIC DISEASE; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG EFFICACY; DRUG TREATMENT FAILURE; ECZEMA; EPIPHORA; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INCIDENCE; INFANCY; INFANT; INFANT DISEASE; LACTOBACILLUS PARACASEI; LACTOBACILLUS RHAMNOSUS; META ANALYSIS; PHYSICAL EXAMINATION; PREGNANCY; PRICK TEST; PRIORITY JOURNAL; PROPHYLAXIS; PUERPERIUM; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHINOCONJUNCTIVITIS; RHINORRHEA; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SNEEZING; SPIROMETRY; STRUCTURED INTERVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; WHEEZING; ABNORMAL RESPIRATORY SOUND; AGE; CONJUNCTIVITIS, ALLERGIC; HYPERSENSITIVITY, IMMEDIATE; NEWBORN; ODDS RATIO; RHINITIS, ALLERGIC;

AGE FACTORS; ASTHMA; CONJUNCTIVITIS, ALLERGIC; ECZEMA; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INFANT; INFANT, NEWBORN; ODDS RATIO; PROBIOTICS; RESPIRATORY SOUNDS; RHINITIS, ALLERGIC;

EID: 84945466289     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12700     Document Type: Review

References (55)

1. Mallol J, Crane J, von Mutius E, Odhiambo J, Keil U, Stewart A,. The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three: a global synthesis. Allergol Immunopathol (Madr) 2013; 41: 73-85.
2. Von Mutius E,. The burden of childhood asthma. Arch Dis Child 2000; 82 (Suppl 2): II2-II5.
3. Meltzer EO, Bukstein DA,. The economic impact of allergic rhinitis and current guidelines for treatment. Ann Allergy Asthma Immunol 2011; 106: S12-S16.
4. Ricci G, Bendandi B, Pagliara L, Patrizi A, Masi M,. Atopic dermatitis in Italian children: evaluation of its economic impact. J Pediatr Health Care 2006; 20: 311-315.
5. Ellis CN, Drake LA, Prendergast MM, Abramovits W, Boguniewicz M, Daniel CR, et al., Cost of atopic dermatitis and eczema in the United States. J Am Acad Dermatol 2002; 46: 361-370.
6. Barbeau M, Bpharm HL,. Burden of atopic dermatitis in Canada. Int J Dermatol 2006; 45: 31-36.
7. Strachan DP,. Hay fever, hygiene, and household size. BMJ 1989; 299: 1259-1260.
8. Romagnani S,. Human TH1 and TH2 subsets: regulation of differentiation and role in protection and immunopathology. Int Arch Allergy Immunol 1992; 98: 279-285.
9. Bendiks M, Kopp MV,. The relationship between advances in understanding the microbiome and the maturing hygiene hypothesis. Curr Allergy Asthma Rep 2013; 13: 487-494.
10. Sanders ME, Guarner F, Guerrant R, Holt PR, Quigley EMM, Sartor RB, et al., An update on the use and investigation of probiotics in health and disease. Gut 2013; 62: 787-796.
11. Thomas DW, Greer FR,. Probiotics and prebiotics in pediatrics. Pediatrics 2010; 126: 1217-1231.
12. Muraro A, Halken S, Arshad SH, Beyer K, Dubois AEJ, Du Toit G, et al., EAACI food allergy and anaphylaxis guidelines. Primary prevention of food allergy. Allergy 2014; 69: 590-601.
13. Moher D, Liberati A, Tetzlaff J, Altman DG,. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
14. Greenhalgh T, Peacock R,. Effectiveness and efficiency of search methods in systematic reviews of complex evidence: audit of primary sources. BMJ 2005; 331: 1064-1065.
15. Higgins JP, Green S,. Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Collab. 2011. http://handbook.cochrane.org/
16. Hardy RJ, Thompson SG,. Detecting and describing heterogeneity in meta-analysis. Stat Med 1998; 17: 841-856.
17. Wickens K, Stanley TV, Mitchell EA, Barthow C, Fitzharris P, Purdie G, et al., Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization? Clin Exp Allergy 2013; 43: 1048-1057.
18. Abrahamsson TR, Jakobsson T, Björkstén B, Oldaeus G, Jenmalm MC,. No effect of probiotics on respiratory allergies: a seven-year follow-up of a randomized controlled trial in infancy. Pediatr Allergy Immunol 2013; 24: 556-561.
19. Rautava S, Kainonen E, Salminen S, Isolauri E,. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J Allergy Clin Immunol 2012; 130: 1355-1360.
20. Ou C-Y, Kuo H-C, Wang L, Hsu T-Y, Chuang H, Liu C-A, et al., Prenatal and postnatal probiotics reduces maternal but not childhood allergic diseases: a randomized, double-blind, placebo-controlled trial. Clin Exp Allergy 2012; 42: 1386-1396.
21. Wickens K, Black P, Stanley TV, Mitchell E, Barthow C, Fitzharris P, et al., A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years. Clin Exp Allergy 2012; 42: 1071-1079.
22. Boyle RJ, Ismail IH, Kivivuori S, Licciardi PV, Robins-Browne RM, Mah L-J, et al., Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial. Allergy 2011; 66: 509-516.
23. Kim JY, Kwon JH, Ahn SH, Il Lee S, Han YS, Choi YO, et al., Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial. Pediatr Allergy Immunol 2010; 21: 386-393.
24. Niers L, Martín R, Rijkers G, Sengers F, Timmerman H, van Uden N, et al., The effects of selected probiotic strains on the development of eczema (the PandA study). Allergy 2009; 64: 1349-1358.
25. Prescott SL, Wiltschut J, Taylor A, Westcott L, Jung W, Currie H, et al., Early markers of allergic disease in a primary prevention study using probiotics: 2.5-year follow-up phase. Allergy 2008; 63: 1481-1490.
26. Wickens K, Black PN, Stanley TV, Mitchell E, Fitzharris P, Tannock GW, et al., A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2008; 122: 788-794.
27. Huurre A, Laitinen K, Rautava S, Korkeamäki M, Isolauri E,. Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization: a double-blind placebo-controlled study. Clin Exp Allergy 2008; 38: 1342-1348.
28. Kopp MV, Hennemuth I, Heinzmann A, Urbanek R,. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 2008; 121: 850-856.
29. Abrahamsson TR, Jakobsson T, Böttcher MF, Fredrikson M, Jenmalm MC, Björkstén B, et al., Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2007; 119: 1174-1180.
30. Taylor AL, Dunstan JA, Prescott SL,. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol 2007; 119: 184-191.
31. Rautava S, Kalliomäki M, Isolauri E,. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 2002; 109: 119-121.
32. Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E,. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet (London, England) 2001; 357: 1076-1079.
33. Böttcher MF, Abrahamsson TR, Fredriksson M, Jakobsson T, Björkstén B,. Low breast milk TGF-beta2 is induced by Lactobacillus reuteri supplementation and associates with reduced risk of sensitization during infancy. Pediatr Allergy Immunol 2008; 19: 497-504.
34. Garcia-Aymerich J, Benet M, Saeys Y, Pinart M, Basagaña X, Smit HA, et al., Phenotyping asthma, rhinitis and eczema in MeDALL population-based birth cohorts: an allergic comorbidity cluster. Allergy 2015; 70: 973-984.
35. Global Initiative for Asthma. GINA Report, Global strategy for asthma management and prevention. 2007. Available from: www.ginasthma.org/local/uploads/files/GINA-Report-072007-1.pdf (accessed 1 July 2015).
36. Bousquet J, Dahl R, Khaltaev N,. Global alliance against chronic respiratory diseases. Allergy 2007; 62: 216-223.
37. Bousquet J, Van Cauwenberge P, Khaltaev N,. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108: S147-S334.
38. Von Mutius E,. Epidemiology of asthma: ISAAC-International Study of Asthma and Allergies in Childhood. Pediatr Allergy Immunol 1996; 7: 54-56.
39. Osborn DA, Sinn JK,. Probiotics in infants for prevention of allergic disease and food hypersensitivity. Cochrane Database Syst Rev 2007; 4: CD006475.
40. Pelucchi C, Chatenoud L, Turati F, Galeone C, Moja L, Bach J-F, et al., Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis. Epidemiology 2012; 23: 402-414.
41. Lee J, Seto D, Bielory L,. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol 2008; 121: 116-121.
42. Frei R, Lauener RP, Crameri R, O'Mahony L,. Microbiota and dietary interactions: an update to the hygiene hypothesis? Allergy 2012; 67: 451-461.
43. West CE, Jenmalm MC, Prescott SL,. The gut microbiota and its role in the development of allergic disease: a wider perspective. Clin Exp Allergy 2015; 45: 43-53.
44. Rautava S, Luoto R, Salminen S, Isolauri E,. Microbial contact during pregnancy, intestinal colonization and human disease. Nat Rev Gastroenterol Hepatol 2012; 9: 565-576.
45. Guarner F, Malagelada J-R,. Gut flora in health and disease. Lancet 2003; 361: 512-519.
46. Forno E, Onderdonk AB, McCracken J, Litonjua AA, Laskey D, Delaney ML, et al., Diversity of the gut microbiota and eczema in early life. Clin Mol Allergy 2008; 6: 11.
47. Dang D, Zhou W, Lun ZJ, Mu X, Wang DX, Wu H,. Meta-analysis of probiotics and/or prebiotics for the prevention of eczema. J Int Med Res 2013; 41: 1426-1436.
48. Dotterud CK, Storrø O, Johnsen R, Øien T,. Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial. Br J Dermatol 2010; 163: 616-623.
49. Soh SE, Aw M, Gerez I, Chong YS, Rauff M, Ng YPM, et al., Probiotic supplementation in the first 6 months of life in at risk Asian infants-effects on eczema and atopic sensitization at the age of 1 year. Clin Exp Allergy 2009; 39: 571-578.
50. Rautava S, Arvilommi H, Isolauri E,. Specific probiotics in enhancing maturation of IgA responses in formula-fed infants. Pediatr Res 2006; 60: 221-224.
51. West CE, Hammarström M-L, Hernell O,. Probiotics during weaning reduce the incidence of eczema. Pediatr Allergy Immunol 2009; 20: 430-437.
52. Elazab N, Mendy A, Gasana J, Vieira ER, Quizon A, Forno E,. Probiotic administration in early life, atopy, and asthma: a meta-analysis of clinical trials. Pediatrics 2013; 132: 666-676.
53. Tang MLK, Lahtinen SJ, Boyle RJ,. Probiotics and prebiotics: clinical effects in allergic disease. Curr Opin Pediatr 2010; 22: 626-634.
54. Dugoua J-J, Machado M, Zhu X, Chen X, Koren G, Einarson TR,. Probiotic safety in pregnancy: a systematic review and meta-analysis of randomized controlled trials of Lactobacillus, Bifidobacterium, and Saccharomyces spp. J Obstet Gynaecol Can 2009; 31: 542-552.
55. Isolauri E,. Dietary modification of atopic disease: use of probiotics in the prevention of atopic dermatitis. Curr Allergy Asthma Rep 2004; 4: 270-275.